Advertisement
Research Article| Volume 41, ISSUE 12, P1710-1714, August 2005

Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort

  • M. Watson
    Correspondence
    Corresponding author. Tel.: +44 20 8661 3510/3009; fax: +44 20 8661 6250/3186
    Affiliations
    Department of Psychological Medicine, Royal Marsden Hospital NHS Trust, Downs Road, Sutton SM2 5PT, UK

    Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton SM2 5NG, UK
    Search for articles by this author
  • Janis Homewood
    Affiliations
    Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton SM2 5NG, UK
    Search for articles by this author
  • Jo Haviland
    Affiliations
    Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton SM2 5NG, UK
    Search for articles by this author
  • Judith M. Bliss
    Affiliations
    Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton SM2 5NG, UK
    Search for articles by this author

      Abstract

      The possibility that psychological response within a few weeks of a breast cancer diagnosis can influence the outcome of the disease is a contentious issue. Psychological response, including helplessness/hopelessness, fighting spirit and depression was assessed in early-stage breast cancer patients between 1 and 3 months post-diagnosis, in order to ascertain effect on cancer prognosis. Patients were followed up for a period of 10 years in order to clarify the effect of psychological response on disease outcome. After 10 years, there is a continuing effect of helplessness/hopelessness on disease-free survival (adjusted hazard ratio (HR) 1.53, 95% confidence interval (CI) 1.11–2.11) but not of depression (adjusted HR for overall survival for ‘cases’ 2.43, 95% CI 0.97–6.10). Longer follow-up also indicates that a high fighting spirit confers no survival advantage. The results showed that, in patients who were disease-free at 5 years, their baseline helpless/hopeless response still exerted a significant effect on disease-free survival beyond 5 (and up to 10) years. The effect is therefore maintained for up to 10 years of follow-up. Clinicians may wish to screen for helplessness around the time of diagnosis in order to target psychological care resources. Further large studies, with similarly prolonged follow-up, are needed to replicate this effect and clarify its mechanism of action.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Watson M.
        • Haviland J.S.
        • Greer S.
        • et al.
        Influence of psychological response on survival in breast cancer: a population-based cohort study.
        Lancet. 1999; 354: 133-136
        • Greer S.
        • Morris T.
        • Pettingale K.W.
        Psychological response to breast cancer; effect on outcome.
        Lancet. 1979; ii: 785-787
        • Pettingale K.W.
        • Morris T.
        • Greer S.
        • et al.
        Mental attitude to cancer; an additional prognostic factor.
        Lancet. 1985; I: 750
        • Watson M.
        • Greer S.
        • Young J.
        • et al.
        Development of a questionnaire measure of adjustment to cancer: the MAC scale.
        Psychol Med. 1988; 19: 203-209
        • Zigmond A.S.
        • Snaith R.P.
        The Hospital Anxiety and Depression Scale.
        Acta Psychiatr Scand. 1983; 67: 361-370
        • Cox D.R.
        Regression models and life tables (with discussion).
        J Roy Stat Soc B. 1972; 74: 187-220
        • Tjemsland L.
        • Søreide J.A.
        • Matre R.
        • et al.
        Pre-operative psychological variables predict immunological status in patients with operable breast cancer.
        Psycho-oncology. 1997; 6: 311-320
        • Seppelt S.
        • Neises M.
        Cortisol, immune status and patient’s coping in primary breast cancer.
        Onkologie. 1998; 21: 496-502
        • Ayres A.
        • Hoon P.W.
        • Franzoni J.B.
        • et al.
        Influence of mood and adjustment o cancer on compliance with chemotherapy among breast cancer patients.
        J Psychosom Res. 1994; 38: 393-402
        • Briere J.
        Lutz F.L. Cognitive Distortion Scales Professional Manual. Psychological Assessment Resources, Lutz, FL, USA2000
        • Greer S.
        • Moorey S.
        • Baruch J.D.R.
        • et al.
        Adjuvant psychological therapy for patients with cancer: a prospective randomised trial.
        Br Med J. 1992; 304: 675-680
        • Spiegel D.
        Mind matters – group therapy and survival in breast cancer (editorial).
        N Engl J Med. 2001; 345: 1767-1768
        • Smedslund G.
        • Ringdal G.I.
        Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients.
        J Psychosom Res. 2004; 57: 123-131